Perry Venugopal is the President & Chief Operating Officer at Casper Pharma. Perry is a strategically-focused Pharma Professional with 20 years of experience spanning Business Development, Pharmaceutical R&D, Operations, Technology and Big-4 Consulting.
Perry’s strengths are his understanding of global pharmaceutical markets, financial & competitive landscape analysis, commercialization strategies, product development and regulatory environment across US and global markets.
At Casper, Perry is responsible for the overall P&L, Operations, Supply Chain, Finance, Technology, Performance Management and strategic initiatives.
Prior to Casper, Perry was at Sun Pharma and Sun’s affiliate – Taro Pharma, where he led business development in the US. In addition to his business development role, he managed the post-merger integration activities between Sun, Taro and Ranbaxy in North America.
Prior to Sun, Perry spent 10 years at Forest Labs in various functions - spanning Technology, R&D Operations and eventually transitioning into Business Development & Strategic Planning.
In his BD role at Forest, he was responsible for managing Forest's $200M legacy portfolio and managing key alliances for their branded business. Prior to Forest, his work experience spans enterprise IT roles in Sanofi-Aventis and consulting for Fortune 500 clients in the healthcare sector for Ernst & Young and IBM Global Services.
Apart from Pharma, Perry is passionate about volunteering and social enterprises and has co-authored a case study for London Business School focusing on Scalability of Social Enterprises.
He serves in an advisory capacity on the board of a couple of social enterprises and has led several community-focused volunteering efforts.
Perry is a Sloan Fellow from London Business School and has an undergraduate degree from BITS, Pilani, India and a Master’s degree from University of Toledo.